☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - August 2020

The Scottish Medicines Consortium (SMC) has resumed issuing its monthly advice on newly licensed medicines.

Hydroxycarbamide oral solution (Xromi®) has been accepted for restricted for use in the prevention of vaso-occlusive complications of Sickle Cell Disease in patients over 2 years of age. The restriction limits use to children who are too young to be able to swallow capsules / tablets and adults and adolescents who have difficulty in swallowing solid oral dosage forms.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - August 2020' by emailShare 'SMC Update - August 2020' on FacebookShare 'SMC Update - August 2020' on TwitterShare 'SMC Update - August 2020' on LinkedInShare 'SMC Update - August 2020' on reddit


No Comments to “SMC Update - August 2020”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.